首页 > 最新文献

Laboratory Investigation最新文献

英文 中文
The Molecular Landscape of 227 Adult Granulosa Cell Tumors of the Ovary: Insights into the Progression from Primary to Recurrence 227例成人卵巢颗粒细胞瘤的分子图谱:从原发到复发的进展。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-29 DOI: 10.1016/j.labinv.2024.102201
Romana Michálková , Adam Šafanda , Nikola Hájková , Jan Hojný , Eva Krkavcová , Michaela Kendall Bártů , Marián Švajdler , Tetiana Shatokhina , Jan Laco , Radoslav Matěj , Gábor Méhes , Jitka Hausnerová , Jozef Škarda , Mária Hácová , Monika Náležinská , Tomáš Zima , Pavel Dundr , Kristýna Němejcová
Adult granulosa cell tumors (AGCTs) of the ovary are characterized by their propensity for late recurrences and are primarily managed surgically due to the limited efficacy of systemic treatment. The FOXL2 p.C134W somatic mutation has been identified in ∼95% of AGCT cases, and TERT promoter alterations have been linked to worse overall survival. This study highlights the potential prognostic significance of FOXO1 mutations, suggesting that they may be associated with poorer overall survival and shorter time to recurrence. A total of 183 primary AGCTs and 44 recurrences without corresponding primary tumors were analyzed. The primary AGCTs were categorized into 3 groups: 77 nonrecurrent tumors, 18 tumors that later recurred (including 9 cases with matched primary-recurrence pairs), and 88 tumors with unknown recurrence status. Targeted next-generation sequencing was conducted on 786 cancer-related genes to investigate their genetic profile. The study aimed to identify the molecular alterations associated with AGCT pathogenesis and recurrence rate, comparing primary versus recurrent tumors, and primary recurrent versus primary nonrecurrent cases.
Our findings confirmed the high prevalence (99%) of the FOXL2 p.C134W mutation in AGCTs. Secondary truncating FOXL2 mutations were observed in 5% of cases. Two cases with typical AGCT morphology were FOXL2 wild-type, harboring mutations in KRAS or KMT2D instead, suggesting alternative genetic pathways. TERT promoter mutations were found in 43% of cases, more frequently in recurrences. Other recurrent mutations detected in the cohort included KMT2D (10%), FOXO1 (7%), CHEK2 (5%), TP53 (3.5%), PIK3CA (3.5%), and AKT1 (3%). Two recurrent, FOXL2-mutated cases also carried DICER1 mutations. One tumor exhibited MSI-high status and a tumor mutation burden of 19 mut/Mb.Our results indicate the need for further investigation into the role of FOXO1 as a potential prognostic marker in AGCTs.
卵巢成人颗粒细胞瘤(agct)的特点是晚期复发的倾向,由于全身治疗的效果有限,主要采用手术治疗。在约95%的AGCT病例中发现了FOXL2 p.C134W体细胞突变,TERT启动子的改变与更差的总生存率有关。这项研究强调了FOXO1突变的潜在预后意义,表明它们可能与较差的总生存率和较短的复发时间有关。我们共分析了183例原发agct和44例无相应原发肿瘤的复发。原发agct分为3组:未复发77例,后来复发18例(其中原发复发配对9例),复发状态未知88例。对786个癌症相关基因进行了定向下一代测序,研究其遗传谱。该研究旨在确定与AGCT发病机制和复发率相关的分子改变,比较原发性与复发性肿瘤,以及原发性复发与原发性非复发病例。我们的研究结果证实了agct中FOXL2 p.C134W突变的高患病率(99%)。在5%的病例中观察到继发性截断的FOXL2突变。2例典型AGCT形态为FOXL2野生型,携带KRAS或KMT2D突变,提示有其他遗传途径。43%的病例中发现TERT启动子突变,更常见的是复发。在队列中检测到的其他复发突变包括KMT2D(10%)、FOXO1(7%)、CHEK2(5%)、TP53(3.5%)、PIK3CA(3.5%)和AKT1(3%)。两个复发的foxl2突变病例也携带DICER1突变。1例肿瘤表现为MSI-High状态,TMB为19 mut/Mb。我们的结果表明,需要进一步研究FOXO1作为agct潜在预后标志物的作用。
{"title":"The Molecular Landscape of 227 Adult Granulosa Cell Tumors of the Ovary: Insights into the Progression from Primary to Recurrence","authors":"Romana Michálková ,&nbsp;Adam Šafanda ,&nbsp;Nikola Hájková ,&nbsp;Jan Hojný ,&nbsp;Eva Krkavcová ,&nbsp;Michaela Kendall Bártů ,&nbsp;Marián Švajdler ,&nbsp;Tetiana Shatokhina ,&nbsp;Jan Laco ,&nbsp;Radoslav Matěj ,&nbsp;Gábor Méhes ,&nbsp;Jitka Hausnerová ,&nbsp;Jozef Škarda ,&nbsp;Mária Hácová ,&nbsp;Monika Náležinská ,&nbsp;Tomáš Zima ,&nbsp;Pavel Dundr ,&nbsp;Kristýna Němejcová","doi":"10.1016/j.labinv.2024.102201","DOIUrl":"10.1016/j.labinv.2024.102201","url":null,"abstract":"<div><div>Adult granulosa cell tumors (AGCTs) of the ovary are characterized by their propensity for late recurrences and are primarily managed surgically due to the limited efficacy of systemic treatment. The <em>FOXL2</em> p.C134W somatic mutation has been identified in ∼95% of AGCT cases, and <em>TERT</em> promoter alterations have been linked to worse overall survival. This study highlights the potential prognostic significance of <em>FOXO1</em> mutations, suggesting that they may be associated with poorer overall survival and shorter time to recurrence. A total of 183 primary AGCTs and 44 recurrences without corresponding primary tumors were analyzed. The primary AGCTs were categorized into 3 groups: 77 nonrecurrent tumors, 18 tumors that later recurred (including 9 cases with matched primary-recurrence pairs), and 88 tumors with unknown recurrence status. Targeted next-generation sequencing was conducted on 786 cancer-related genes to investigate their genetic profile. The study aimed to identify the molecular alterations associated with AGCT pathogenesis and recurrence rate, comparing primary versus recurrent tumors, and primary recurrent versus primary nonrecurrent cases.</div><div>Our findings confirmed the high prevalence (99%) of the <em>FOXL2</em> p.C134W mutation in AGCTs. Secondary truncating <em>FOXL2</em> mutations were observed in 5% of cases. Two cases with typical AGCT morphology were <em>FOXL2</em> wild-type, harboring mutations in <em>KRAS</em> or <em>KMT2D</em> instead, suggesting alternative genetic pathways. <em>TERT</em> promoter mutations were found in 43% of cases, more frequently in recurrences. Other recurrent mutations detected in the cohort included <em>KMT2D</em> (10%), <em>FOXO1</em> (7%), <em>CHEK2</em> (5%), <em>TP53</em> (3.5%), <em>PIK3CA</em> (3.5%), and <em>AKT1</em> (3%). Two recurrent, <em>FOXL2</em>-mutated cases also carried <em>DICER1</em> mutations. One tumor exhibited MSI-high status and a tumor mutation burden of 19 mut/Mb.Our results indicate the need for further investigation into the role of <em>FOXO1</em> as a potential prognostic marker in AGCTs.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 3","pages":"Article 102201"},"PeriodicalIF":5.1,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland Neoplasms NKX3.1有助于区分透明细胞癌与其他透明细胞唾液腺肿瘤。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-29 DOI: 10.1016/j.labinv.2024.102205
Airi Sakyo , Eijitsu Ryo , Shogo Nishino , Kenya Kobayashi , Seiichi Yoshimoto , Go Omura , Chihiro Fushimi , Toshihiko Sakai , Azusa Sakai , Kohtaro Eguchi , Hideaki Takahashi , Kazuki Yokoyama , Yoshitaka Honma , Akiko Mori , Hiroko Kato , Toshiyuki Hatano , Akihiko Yoshida , Fumihiko Matsumoto , Yasushi Yatabe , Taisuke Mori
Hyalinized clear cell carcinoma (HCCC) is a rare tumor of the minor salivary gland, characterized by pale cytoplasm and EWSR1::ATF1 fusion. Recently, new fusions, such as EWSR1::LARP4 and SMARCA2::CREM, have also been identified. Histologically, HCCC closely resembles other salivary gland tumors like mucoepidermoid carcinoma and myoepithelial carcinoma, and there are no specific immunohistological markers for its identification. In this study, we investigated potential markers for HCCC based on the characteristics of minor salivary gland acini, from which these tumors may originate. SOX10 is a known marker for serous gland clusters and NKX3.1 for mucus gland clusters. Fluorescence intensity analysis of double staining, objectively evaluated by artificial intelligence, revealed variations in the positive intensity of cells single positive for NKX3.1 and SOX10, as well as cells positive for both markers, which are commonly observed in normal minor salivary glands. We evaluated NKX3.1 expression by immunohistochemistry in 12 HCCC cases (including 9 EWSR1::ATF1, 1 EWSR1::LARP4, and 1 SMARCA2::CREM), 12 myoepithelial carcinoma cases, and tissue microarray containing 88 cases of multiple salivary gland tumors using immunohistochemistry. NKX3.1 was expressed in all 12 HCCC cases (100%), with NKX3.1-positive cells ≧90% in 3 cases, ≧60% 1 case, ≧30% 4 cases, and <30% 4 cases, respectively. SOX10 was negative in 10 cases and weakly positive in 2 cases. This finding mimics the pattern of expression in minor salivary glands and may explain the occurrence of weak NKX3.1 staining and SOX10-positive cases in HCCC. Additionally, in the tissue microarray analysis, NKX3.1 staining was observed in only 1 HCCC case. These findings indicate that NKX3.1 is a useful marker for distinguishing HCCC from other clear cell salivary gland neoplasms. This study suggests that NKX3.1, along with SOX10 and CK7, can be utilized to improve the accuracy of HCCC diagnosis.
透明细胞癌(HCCC)是一种罕见的小唾液腺肿瘤,其特征是细胞质苍白和EWSR1::ATF1融合。最近,新的融合基因如EWSR1::LARP4和SMARCA2::CREM也被发现。在组织学上,HCCC与其他唾液腺肿瘤如粘液表皮样癌和肌上皮癌非常相似,没有特异性的免疫组织学标记物来识别。在这项研究中,我们根据小涎腺腺泡的特征研究了HCCC的潜在标记物,这些肿瘤可能起源于小涎腺腺泡。SOX10是已知的浆液腺簇的标记物,NKX3.1是粘液腺簇的标记物。人工智能客观评价双染色的荧光强度分析,揭示了在正常小唾液腺中常见的NKX3.1和SOX10单阳性细胞以及两种标记物均阳性细胞的阳性强度变化。采用免疫组化方法对12例HCCC(包括9例EWSR1::ATF1、1例EWSR1::LARP4和1例SMARCA2::CREM)、12例肌上皮癌和包含88例多发性涎腺肿瘤的组织微阵列(TMA)患者的NKX3.1表达进行了检测。12例HCCC病例均表达NKX3.1(100%),其中NKX3.1阳性细胞≧90% 4例3例,≧60% 1例,≧30% 5例4例
{"title":"NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland Neoplasms","authors":"Airi Sakyo ,&nbsp;Eijitsu Ryo ,&nbsp;Shogo Nishino ,&nbsp;Kenya Kobayashi ,&nbsp;Seiichi Yoshimoto ,&nbsp;Go Omura ,&nbsp;Chihiro Fushimi ,&nbsp;Toshihiko Sakai ,&nbsp;Azusa Sakai ,&nbsp;Kohtaro Eguchi ,&nbsp;Hideaki Takahashi ,&nbsp;Kazuki Yokoyama ,&nbsp;Yoshitaka Honma ,&nbsp;Akiko Mori ,&nbsp;Hiroko Kato ,&nbsp;Toshiyuki Hatano ,&nbsp;Akihiko Yoshida ,&nbsp;Fumihiko Matsumoto ,&nbsp;Yasushi Yatabe ,&nbsp;Taisuke Mori","doi":"10.1016/j.labinv.2024.102205","DOIUrl":"10.1016/j.labinv.2024.102205","url":null,"abstract":"<div><div>Hyalinized clear cell carcinoma (HCCC) is a rare tumor of the minor salivary gland, characterized by pale cytoplasm and EWSR1::ATF1 fusion. Recently, new fusions, such as EWSR1::LARP4 and SMARCA2::CREM, have also been identified. Histologically, HCCC closely resembles other salivary gland tumors like mucoepidermoid carcinoma and myoepithelial carcinoma, and there are no specific immunohistological markers for its identification. In this study, we investigated potential markers for HCCC based on the characteristics of minor salivary gland acini, from which these tumors may originate. SOX10 is a known marker for serous gland clusters and NKX3.1 for mucus gland clusters. Fluorescence intensity analysis of double staining, objectively evaluated by artificial intelligence, revealed variations in the positive intensity of cells single positive for NKX3.1 and SOX10, as well as cells positive for both markers, which are commonly observed in normal minor salivary glands. We evaluated NKX3.1 expression by immunohistochemistry in 12 HCCC cases (including 9 EWSR1::ATF1, 1 EWSR1::LARP4, and 1 SMARCA2::CREM), 12 myoepithelial carcinoma cases, and tissue microarray containing 88 cases of multiple salivary gland tumors using immunohistochemistry. NKX3.1 was expressed in all 12 HCCC cases (100%), with NKX3.1-positive cells ≧90% in 3 cases, ≧60% 1 case, ≧30% 4 cases, and &lt;30% 4 cases, respectively. SOX10 was negative in 10 cases and weakly positive in 2 cases. This finding mimics the pattern of expression in minor salivary glands and may explain the occurrence of weak NKX3.1 staining and SOX10-positive cases in HCCC. Additionally, in the tissue microarray analysis, NKX3.1 staining was observed in only 1 HCCC case. These findings indicate that NKX3.1 is a useful marker for distinguishing HCCC from other clear cell salivary gland neoplasms. This study suggests that NKX3.1, along with SOX10 and CK7, can be utilized to improve the accuracy of HCCC diagnosis.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 3","pages":"Article 102205"},"PeriodicalIF":5.1,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Annotation Practices in Computational Pathology: A European Society of Digital and Integrative Pathology (ESDIP) Survey Study 计算病理学中的注释实践:欧洲数字和综合病理学协会(ESDIP)调查研究。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-29 DOI: 10.1016/j.labinv.2024.102203
Diana Montezuma , Sara P. Oliveira , Yuri Tolkach , Peter Boor , Alex Haragan , Rita Carvalho , Vincenzo Della Mea , Tim-Rasmus Kiehl , Sabine Leh , Mustafa Yousif , David Ameisen , Mircea-Sebastian Șerbănescu , Norman Zerbe , Vincenzo L’Imperio
Integrating digital pathology and artificial intelligence (AI) algorithms can potentially improve diagnostic practice and precision medicine. Developing reliable, generalizable, and comparable AI algorithms depends on access to meticulously annotated data. However, achieving this requires robust collaboration among pathologists, computer scientists, and other researchers to ensure data quality and consistency. The lack of standardization and scalability is a significant challenge when generating annotations and annotated data sets. Recognizing these limitations, the Scientific Committee of the European Society of Digital and Integrative Pathology (ESDIP) performed a comprehensive international survey to understand the current state of annotation practices and identify actionable areas to address critical needs in the annotation process. The analysis and summary of the survey results provide several insights for all stakeholders involved in data preparation and ground truthing, ultimately contributing to the advancement of AI in computational pathology.
整合数字病理学(DP)和人工智能(AI)算法可以潜在地改善诊断实践和精准医疗。开发可靠的、可推广的、可比较的人工智能算法依赖于对精心注释的数据的访问。然而,实现这一目标需要病理学家、计算机科学家和其他研究人员之间的紧密合作,以确保数据的质量和一致性。在生成注释和带注释的数据集时,缺乏标准化和可伸缩性是一个重大挑战。认识到这些局限性,欧洲数字与综合病理学学会(ESDIP)科学委员会进行了一项全面的国际调查,以了解注释实践的现状,并确定可操作的领域,以解决注释过程中的关键需求。对调查结果的分析和总结为参与数据准备和实地调查的所有利益相关者提供了一些见解,最终有助于人工智能在计算病理学方面的进步。
{"title":"Annotation Practices in Computational Pathology: A European Society of Digital and Integrative Pathology (ESDIP) Survey Study","authors":"Diana Montezuma ,&nbsp;Sara P. Oliveira ,&nbsp;Yuri Tolkach ,&nbsp;Peter Boor ,&nbsp;Alex Haragan ,&nbsp;Rita Carvalho ,&nbsp;Vincenzo Della Mea ,&nbsp;Tim-Rasmus Kiehl ,&nbsp;Sabine Leh ,&nbsp;Mustafa Yousif ,&nbsp;David Ameisen ,&nbsp;Mircea-Sebastian Șerbănescu ,&nbsp;Norman Zerbe ,&nbsp;Vincenzo L’Imperio","doi":"10.1016/j.labinv.2024.102203","DOIUrl":"10.1016/j.labinv.2024.102203","url":null,"abstract":"<div><div>Integrating digital pathology and artificial intelligence (AI) algorithms can potentially improve diagnostic practice and precision medicine. Developing reliable, generalizable, and comparable AI algorithms depends on access to meticulously annotated data. However, achieving this requires robust collaboration among pathologists, computer scientists, and other researchers to ensure data quality and consistency. The lack of standardization and scalability is a significant challenge when generating annotations and annotated data sets. Recognizing these limitations, the Scientific Committee of the European Society of Digital and Integrative Pathology (ESDIP) performed a comprehensive international survey to understand the current state of annotation practices and identify actionable areas to address critical needs in the annotation process. The analysis and summary of the survey results provide several insights for all stakeholders involved in data preparation and ground truthing, ultimately contributing to the advancement of AI in computational pathology.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 3","pages":"Article 102203"},"PeriodicalIF":5.1,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive RNA Sequencing Analysis Identifies Network Hub Genes and Biomarkers Differentiating Desmoid-type Fibromatosis From Reactive Fibrosis 综合RNA-seq分析鉴定网络中心基因和生物标志物区分纤维瘤病和反应性纤维化。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-29 DOI: 10.1016/j.labinv.2024.102204
Eunjin Jeong , Jamin Ku , Ji Min Na , Wonkyung Kim , Chang Ohk Sung , Seok-Hyung Kim
Desmoid-type fibromatosis (DTF) is a benign but locally aggressive neoplasm characterized by persistent fibroblast activation, unlike reactive fibrosis (RF), where fibroblast activation is transient. Although the Wnt/β-catenin signaling pathway is known to play a role in DTF pathogenesis, the specific genetic drivers contributing to this abnormal fibroblast activation are not fully understood. To identify additional driver genes that underlie the persistent activation of fibroblasts in DTF, we conducted a comparative transcriptome analysis between 29 DTF and 14 RF tissue samples, identifying 4267 differentially expressed genes (DEGs) specific to DTF. These DTF-specific DEGs were significantly associated with pathways involved in embryonic limb morphogenesis and muscle contraction, whereas RF-specific DEGs were linked to immune response and apoptosis. Using weighted gene coexpression network analysis to further elucidate the key regulatory circuits associated with persistent activation of DTF fibroblasts, we identified a highly DTF-specific gene module comprising 120 genes. This module was also significantly enriched in other fibroproliferative conditions showing persistent fibroblast activation, such as keloid disease and idiopathic pulmonary fibrosis. Subsequent analyses identified 7 driver transcription factors (ZNF536, IRX5, TWIST2, NKD2, PAX9, SHOX2, and SALL4) within this DTF-specific module that may contribute to the sustained activation of DTF fibroblasts. We further assessed the utility of 5 key genes from this module (TWIST2, LRRC15, CTHRC1, SHOX2, and SALL4) as potential biomarkers to distinguish DTF from RF using immunohistochemistry. All markers demonstrated excellent diagnostic performance, with TWIST2 showing exceptionally high sensitivity and specificity, surpassing β-catenin, the current standard biomarker for DTF. In conclusion, our study identifies gene modules and driver transcription factors that are highly specific to DTF, offering new insights into the genetic underpinnings of abnormal fibroblast activation in DTF. We also propose novel biomarkers that could improve the diagnostic accuracy and clinical management of DTF.
Desmoid-type纤维瘤病(DTF)是一种良性但局部侵袭性的肿瘤,其特征是持续的成纤维细胞激活,而不像反应性纤维化(RF),成纤维细胞激活是短暂的。虽然已知Wnt/β-catenin信号通路在DTF发病机制中发挥作用,但导致这种异常成纤维细胞激活的特定遗传驱动因素尚未完全了解。为了确定DTF中成纤维细胞持续激活的其他驱动基因,我们对29个DTF和14个RF组织样本进行了比较转录组分析,确定了4267个DTF特异性差异表达基因(DEGs)。这些dtf特异性deg与胚胎肢体形态发生和肌肉收缩相关,而rf特异性deg与免疫反应和细胞凋亡相关。利用加权基因共表达网络分析(WGCNA)进一步阐明与DTF成纤维细胞持续激活相关的关键调控回路,我们确定了一个由120个基因组成的高度DTF特异性基因模块。该模块在其他纤维增生条件下也显著富集,显示出持续的成纤维细胞激活,如瘢痕疙瘩病和特发性肺纤维化。随后的分析确定了DTF特异性模块中的7个驱动转录因子(ZNF536, IRX5, TWIST2, NKD2, PAX9, SHOX2和SALL4),它们可能有助于DTF成纤维细胞的持续激活。我们进一步评估了该模块中的五个关键基因(TWIST2、LRRC15、CTHRC1、SHOX2和SALL4)作为区分DTF和RF的潜在生物标志物的应用。所有标记物均表现出优异的诊断性能,其中TWIST2表现出极高的敏感性和特异性,超过了目前DTF的标准生物标记物β-catenin。总之,我们的研究确定了DTF高度特异性的基因模块和驱动转录因子,为DTF异常成纤维细胞激活的遗传基础提供了新的见解。我们还提出了新的生物标志物,可以提高DTF的诊断准确性和临床管理。
{"title":"Comprehensive RNA Sequencing Analysis Identifies Network Hub Genes and Biomarkers Differentiating Desmoid-type Fibromatosis From Reactive Fibrosis","authors":"Eunjin Jeong ,&nbsp;Jamin Ku ,&nbsp;Ji Min Na ,&nbsp;Wonkyung Kim ,&nbsp;Chang Ohk Sung ,&nbsp;Seok-Hyung Kim","doi":"10.1016/j.labinv.2024.102204","DOIUrl":"10.1016/j.labinv.2024.102204","url":null,"abstract":"<div><div>Desmoid-type fibromatosis (DTF) is a benign but locally aggressive neoplasm characterized by persistent fibroblast activation, unlike reactive fibrosis (RF), where fibroblast activation is transient. Although the Wnt/β-catenin signaling pathway is known to play a role in DTF pathogenesis, the specific genetic drivers contributing to this abnormal fibroblast activation are not fully understood. To identify additional driver genes that underlie the persistent activation of fibroblasts in DTF, we conducted a comparative transcriptome analysis between 29 DTF and 14 RF tissue samples, identifying 4267 differentially expressed genes (DEGs) specific to DTF. These DTF-specific DEGs were significantly associated with pathways involved in embryonic limb morphogenesis and muscle contraction, whereas RF-specific DEGs were linked to immune response and apoptosis. Using weighted gene coexpression network analysis to further elucidate the key regulatory circuits associated with persistent activation of DTF fibroblasts, we identified a highly DTF-specific gene module comprising 120 genes. This module was also significantly enriched in other fibroproliferative conditions showing persistent fibroblast activation, such as keloid disease and idiopathic pulmonary fibrosis. Subsequent analyses identified 7 driver transcription factors (<em>ZNF536, IRX5, TWIST2, NKD2, PAX9, SHOX2,</em> and <em>SALL4</em>) within this DTF-specific module that may contribute to the sustained activation of DTF fibroblasts. We further assessed the utility of 5 key genes from this module (TWIST2, LRRC15, CTHRC1, SHOX2, and SALL4) as potential biomarkers to distinguish DTF from RF using immunohistochemistry. All markers demonstrated excellent diagnostic performance, with TWIST2 showing exceptionally high sensitivity and specificity, surpassing β-catenin, the current standard biomarker for DTF. In conclusion, our study identifies gene modules and driver transcription factors that are highly specific to DTF, offering new insights into the genetic underpinnings of abnormal fibroblast activation in DTF. We also propose novel biomarkers that could improve the diagnostic accuracy and clinical management of DTF.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 3","pages":"Article 102204"},"PeriodicalIF":5.1,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymph Node Metastasis Prediction From In Situ Lung Squamous Cell Carcinoma Histopathology Images Using Deep Learning 利用深度学习从原位肺鳞癌组织病理学图像中预测淋巴结转移。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-13 DOI: 10.1016/j.labinv.2024.102187
Lu Xia , Tao Xu , Yongsheng Zheng , Baohua Li , Yongfang Ao , Xun Li , Weijing Wu , Jiabian Lian
Lung squamous cell carcinoma (LUSC), a subtype of non–small cell lung cancer, represents a significant portion of lung cancer cases with distinct histologic patterns impacting prognosis and treatment. The current pathological assessment methods face limitations such as interobserver variability, necessitating more reliable techniques. This study seeks to predict lymph node metastasis in LUSC using deep learning models applied to histopathology images of primary tumors, offering a more accurate and objective method for diagnosis and prognosis. Whole slide images (WSIs) from the Outdo-LUSC and the cancer genome atlas cohorts were used to train and validate deep learning models. Multiinstance learning was applied, with patch-level predictions aggregated into WSI-level outcomes. The study employed the ResNet-18 network, transfer learning, and rigorous data preprocessing. To represent WSI features, innovative techniques like patch likelihood histogram and bag of words were used, followed by training of machine learning classifiers, including the ExtraTrees algorithm. The diagnostic model for lymph node metastasis showed strong performance, particularly using the ExtraTrees algorithm, as demonstrated by receiver operating characteristic curves and gradient-weighted class activation mapping visualizations. The signature generated by the ExtraTrees algorithm, named lymph node status-related in situ LUSC histopathology (LN_ISLUSCH), achieved an area under the curve of 0.941 (95% CI: 0.926-0.955) in the training set and 0.788 (95% CI: 0.748-0.827) in the test set. Kaplan-Meier analyses confirmed that the LN_ISLUSCH model was a significant prognostic factor (P = .02). This study underscores the potential of artificial intelligence in enhancing diagnostic precision in pathology. The LN_ISLUSCH model stands out as a promising tool for predicting lymph node metastasis and prognosis in LUSC. Future studies should focus on larger and more diverse cohorts and explore the integration of additional omics data to further refine predictive accuracy and clinical utility.
肺鳞状细胞癌(LUSC)是非小细胞肺癌的一个亚型,在肺癌病例中占很大比例,其独特的组织学模式对预后和治疗产生影响。目前的病理评估方法存在观察者之间的差异等局限性,因此需要更可靠的技术。本研究旨在利用应用于原发性肿瘤组织病理学图像的深度学习模型预测肺癌淋巴结转移,为诊断和预后提供更准确、更客观的方法。来自Outdo-LUSC和TCGA-LUSC队列的全切片图像(WSI)被用于训练和验证深度学习模型。应用多实例学习,将斑块级预测结果汇总为WSI级结果。研究采用了 ResNet-18 网络、迁移学习和严格的数据预处理。为了表示 WSI 特征,使用了斑块似然直方图(PLH)和词包(BoW)等创新技术,然后训练机器学习分类器,包括 ExtraTrees 算法。淋巴结转移诊断模型显示出很强的性能,尤其是使用 ExtraTrees 算法时,接收器操作特征曲线(ROC)和 Grad-CAM 可视化效果都证明了这一点。由 ExtraTrees 算法生成的特征被命名为 LN_ISLUSCH(淋巴结状态相关的原位肺鳞癌组织病理学),在训练集中的曲线下面积(AUC)为 0.941(95% CI:0.926-0.955),在测试集中的曲线下面积(AUC)为 0.788(95% CI:0.748-0.827)。Kaplan-Meier 分析证实,LN_ISLUSCH 模型是一个重要的预后因素(p = 0.02)。这项研究强调了人工智能在提高病理诊断精确度方面的潜力。LN_ISLUSCH 模型是预测 LUSC 淋巴结转移和预后的有效工具。未来的研究应侧重于更大、更多样化的队列,并探索整合更多的全息数据,以进一步提高预测准确性和临床实用性。
{"title":"Lymph Node Metastasis Prediction From In Situ Lung Squamous Cell Carcinoma Histopathology Images Using Deep Learning","authors":"Lu Xia ,&nbsp;Tao Xu ,&nbsp;Yongsheng Zheng ,&nbsp;Baohua Li ,&nbsp;Yongfang Ao ,&nbsp;Xun Li ,&nbsp;Weijing Wu ,&nbsp;Jiabian Lian","doi":"10.1016/j.labinv.2024.102187","DOIUrl":"10.1016/j.labinv.2024.102187","url":null,"abstract":"<div><div>Lung squamous cell carcinoma (LUSC), a subtype of non–small cell lung cancer, represents a significant portion of lung cancer cases with distinct histologic patterns impacting prognosis and treatment. The current pathological assessment methods face limitations such as interobserver variability, necessitating more reliable techniques. This study seeks to predict lymph node metastasis in LUSC using deep learning models applied to histopathology images of primary tumors, offering a more accurate and objective method for diagnosis and prognosis. Whole slide images (WSIs) from the Outdo-LUSC and the cancer genome atlas cohorts were used to train and validate deep learning models. Multiinstance learning was applied, with patch-level predictions aggregated into WSI-level outcomes. The study employed the ResNet-18 network, transfer learning, and rigorous data preprocessing. To represent WSI features, innovative techniques like patch likelihood histogram and bag of words were used, followed by training of machine learning classifiers, including the ExtraTrees algorithm. The diagnostic model for lymph node metastasis showed strong performance, particularly using the ExtraTrees algorithm, as demonstrated by receiver operating characteristic curves and gradient-weighted class activation mapping visualizations. The signature generated by the ExtraTrees algorithm, named lymph node status-related in situ LUSC histopathology (LN_ISLUSCH), achieved an area under the curve of 0.941 (95% CI: 0.926-0.955) in the training set and 0.788 (95% CI: 0.748-0.827) in the test set. Kaplan-Meier analyses confirmed that the LN_ISLUSCH model was a significant prognostic factor (<em>P</em> = .02). This study underscores the potential of artificial intelligence in enhancing diagnostic precision in pathology. The LN_ISLUSCH model stands out as a promising tool for predicting lymph node metastasis and prognosis in LUSC. Future studies should focus on larger and more diverse cohorts and explore the integration of additional omics data to further refine predictive accuracy and clinical utility.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 1","pages":"Article 102187"},"PeriodicalIF":5.1,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatiotemporal Cellular Dynamics of Germinal Center Reaction in Coronavirus Disease 2019 Lung-Draining Lymph Node Based on Imaging-Based Spatial Transcriptomics 基于成像的空间转录组学研究COVID-19肺引流淋巴结生殖中心反应的时空细胞动态。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-09 DOI: 10.1016/j.labinv.2024.102180
Taehwan Oh , YoungMin Woo , Green Kim , Bon-Sang Koo , Seung Ho Baek , Eun-Ha Hwang , You Jung An , Yujin Kim , Dong-Yeon Kim , Jung Joo Hong
Although lymph node structures may be compromised in severe SARS-CoV-2 infection, the extent and parameters of recovery in convalescing patients remain unclear. Therefore, this study aimed to elucidate the nuances of lymphoid structural recovery and their implications for immunologic memory in nonhuman primates infected with SARS-CoV-2. To do so, we utilized imaging-based spatial transcriptomics to delineate immune cell composition and tissue architecture formation in the lung-draining lymph nodes during primary infection, convalescence, and reinfection from COVID-19. We noted the establishment of a germinal center with memory B cell differentiation within lymphoid follicles during convalescence accompanied by contrasting transcriptome patterns indicative of the acquisition of follicular helper T cells versus the loss of regulatory T cells. Additionally, repopulation of germinal center-like B cells was observed in the medullary niche with accumulating plasma cells along with enhanced transcriptional expression of B cell-activating factor receptor over the course of reinfection. The spatial transcriptome atlas produced herein enhances our understanding of germinal center formation with immune cell dynamics during COVID-19 convalescence and lymphoid structural recovery with transcriptome dynamics following reinfection. These findings have the potential to inform the optimization of vaccine strategies and the development of precise therapeutic interventions in the spatial context.
虽然淋巴结结构在严重的 SARS-CoV-2 感染中可能受到损害,但康复期患者的恢复程度和参数仍不清楚。因此,本研究旨在阐明感染 SARS-CoV-2 的非人灵长类动物淋巴结构恢复的细微差别及其对免疫记忆的影响。为此,我们利用基于成像的空间转录组学来描述 COVID-19 在原发感染、康复和再感染期间肺部引流淋巴结的免疫细胞组成和组织结构形成。我们注意到,在康复期,淋巴滤泡内建立了具有记忆性 B 细胞分化的生殖中心,同时出现了表明滤泡辅助性 T 细胞获得与调节性 T 细胞丧失的对比转录组模式。此外,在髓质龛中还观察到了生殖中心样 B 细胞的重新增殖,浆细胞不断积累,B 细胞活化因子受体的转录表达在再感染过程中也得到了增强。本文绘制的空间转录组图谱增强了我们对COVID-19康复期生殖中心形成与免疫细胞动态以及再感染后淋巴结构恢复与转录组动态的了解。这些发现有可能为优化疫苗策略和开发精确的空间治疗干预措施提供信息。
{"title":"Spatiotemporal Cellular Dynamics of Germinal Center Reaction in Coronavirus Disease 2019 Lung-Draining Lymph Node Based on Imaging-Based Spatial Transcriptomics","authors":"Taehwan Oh ,&nbsp;YoungMin Woo ,&nbsp;Green Kim ,&nbsp;Bon-Sang Koo ,&nbsp;Seung Ho Baek ,&nbsp;Eun-Ha Hwang ,&nbsp;You Jung An ,&nbsp;Yujin Kim ,&nbsp;Dong-Yeon Kim ,&nbsp;Jung Joo Hong","doi":"10.1016/j.labinv.2024.102180","DOIUrl":"10.1016/j.labinv.2024.102180","url":null,"abstract":"<div><div>Although lymph node structures may be compromised in severe SARS-CoV-2 infection, the extent and parameters of recovery in convalescing patients remain unclear. Therefore, this study aimed to elucidate the nuances of lymphoid structural recovery and their implications for immunologic memory in nonhuman primates infected with SARS-CoV-2. To do so, we utilized imaging-based spatial transcriptomics to delineate immune cell composition and tissue architecture formation in the lung-draining lymph nodes during primary infection, convalescence, and reinfection from COVID-19. We noted the establishment of a germinal center with memory B cell differentiation within lymphoid follicles during convalescence accompanied by contrasting transcriptome patterns indicative of the acquisition of follicular helper T cells versus the loss of regulatory T cells. Additionally, repopulation of germinal center-like B cells was observed in the medullary niche with accumulating plasma cells along with enhanced transcriptional expression of B cell-activating factor receptor over the course of reinfection. The spatial transcriptome atlas produced herein enhances our understanding of germinal center formation with immune cell dynamics during COVID-19 convalescence and lymphoid structural recovery with transcriptome dynamics following reinfection. These findings have the potential to inform the optimization of vaccine strategies and the development of precise therapeutic interventions in the spatial context.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 1","pages":"Article 102180"},"PeriodicalIF":5.1,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying Cardiac Tissue Composition Using QuPath and Cellpose: An Accessible Approach to Postmortem Diagnosis 利用QuPath和Cellpose量化心脏组织成分:尸检诊断的便捷方法SAE.
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-08 DOI: 10.1016/j.labinv.2024.102181
Pernille Heimdal Holm , Kristine Boisen Olsen , Richard Denis Maxime De Mets , Jytte Banner
Sudden death can be the first symptom of cardiac disease, and establishing a precise postmortem diagnosis is crucial for genetic testing and follow-up of relatives. Arrhythmogenic cardiomyopathy is a structural cardiomyopathy that can be challenging to diagnose postmortem because of differences in structural findings and propagation of the disease at the time of death. Cases can have minimal or no structural findings and later be diagnosed according to genotype, known as concealed cardiomyopathy. Postmortem diagnosis often lacks clinical information, whereas antemortem diagnosis is based on paraclinical investigations that cannot be performed after death. However, the entire substrate is available, which is unique to postmortem diagnosis and research and can provide valuable insights when adding new methods. Reactive changes in the heart, such as myocardial fibrosis and fat, are significant findings. The patterns of these changes in various diseases are not yet fully understood and may be limited by sampling material and conventional microscopic diagnostics. We demonstrate an automated pipeline in QuPath for quantifying postmortem picrosirius red cardiac tissue for collagen, residual myocardium, and adipocytes by integrating Cellpose into a versatile pipeline. This method was developed and tested using cardiac tissues from autopsied individuals. Cases diagnosed with arrhythmogenic cardiomyopathy and age-matched controls were used for validation and testing. This approach is free and easy to implement by other research groups using this paper as a template. This can potentially lead to the development of quantitative diagnostic criteria for postmortem cardiac diseases, eliminating the need to rely on diagnostic criteria from endomyocardial biopsies that are not applicable to postmortem specimens. We propose that this approach serves as a template for creating a more efficient process for evaluating postmortem cardiac measurements in an unbiased manner, particularly for rare cardiac diseases.
猝死可能是心脏疾病的首发症状,而确定准确的死后诊断对于基因检测和亲属随访至关重要。心律失常性心肌病(ACM)是一种结构性心肌病,由于死亡时的结构检查结果和疾病传播情况不同,死后诊断具有挑战性。病例可能只有极少或没有结构性发现,但后来根据基因型被诊断为隐匿性心肌病。死后诊断往往缺乏临床信息,而死前诊断则基于死后无法进行的临床旁检查。然而,可以获得整个基质,这是尸检诊断和研究的独特之处,在添加新方法时可以提供有价值的见解。心肌纤维化和脂肪等心脏反应性变化是重要的发现。这些变化在各种疾病中的模式尚不完全清楚,而且可能受到取样材料和传统显微诊断的限制。我们在 QuPath 中展示了一种自动流水线,通过将 Cellpose 集成到多功能流水线中,对死后皮色红心肌组织中的胶原蛋白、残余心肌和脂肪细胞进行量化。这种方法是利用尸体解剖者的心脏组织开发和测试的。确诊为 ACM 的病例和年龄匹配的对照组被用于验证和测试。这种方法是免费的,其他研究小组可以以此为模板轻松实施。这有可能为死后心脏疾病制定定量诊断标准,从而无需依赖心内膜活检的诊断标准,因为这些标准不适用于死后标本。我们建议以这种方法为模板,创建一个更有效的流程,以公正的方式评估死后心脏测量结果,尤其是罕见的心脏疾病。
{"title":"Quantifying Cardiac Tissue Composition Using QuPath and Cellpose: An Accessible Approach to Postmortem Diagnosis","authors":"Pernille Heimdal Holm ,&nbsp;Kristine Boisen Olsen ,&nbsp;Richard Denis Maxime De Mets ,&nbsp;Jytte Banner","doi":"10.1016/j.labinv.2024.102181","DOIUrl":"10.1016/j.labinv.2024.102181","url":null,"abstract":"<div><div>Sudden death can be the first symptom of cardiac disease, and establishing a precise postmortem diagnosis is crucial for genetic testing and follow-up of relatives. Arrhythmogenic cardiomyopathy is a structural cardiomyopathy that can be challenging to diagnose postmortem because of differences in structural findings and propagation of the disease at the time of death. Cases can have minimal or no structural findings and later be diagnosed according to genotype, known as concealed cardiomyopathy. Postmortem diagnosis often lacks clinical information, whereas antemortem diagnosis is based on paraclinical investigations that cannot be performed after death. However, the entire substrate is available, which is unique to postmortem diagnosis and research and can provide valuable insights when adding new methods. Reactive changes in the heart, such as myocardial fibrosis and fat, are significant findings. The patterns of these changes in various diseases are not yet fully understood and may be limited by sampling material and conventional microscopic diagnostics. We demonstrate an automated pipeline in QuPath for quantifying postmortem picrosirius red cardiac tissue for collagen, residual myocardium, and adipocytes by integrating Cellpose into a versatile pipeline. This method was developed and tested using cardiac tissues from autopsied individuals. Cases diagnosed with arrhythmogenic cardiomyopathy and age-matched controls were used for validation and testing. This approach is free and easy to implement by other research groups using this paper as a template. This can potentially lead to the development of quantitative diagnostic criteria for postmortem cardiac diseases, eliminating the need to rely on diagnostic criteria from endomyocardial biopsies that are not applicable to postmortem specimens. We propose that this approach serves as a template for creating a more efficient process for evaluating postmortem cardiac measurements in an unbiased manner, particularly for rare cardiac diseases.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 1","pages":"Article 102181"},"PeriodicalIF":5.1,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selecting Preclinical Animal Models in Hepatology Research: A Call for Uniform Guidelines 在肝脏病学研究中选择临床前动物模型:呼吁制定统一指南。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-08 DOI: 10.1016/j.labinv.2024.102179
Devaraj Ezhilarasan , Mustapha Najimi
{"title":"Selecting Preclinical Animal Models in Hepatology Research: A Call for Uniform Guidelines","authors":"Devaraj Ezhilarasan ,&nbsp;Mustapha Najimi","doi":"10.1016/j.labinv.2024.102179","DOIUrl":"10.1016/j.labinv.2024.102179","url":null,"abstract":"","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 1","pages":"Article 102179"},"PeriodicalIF":5.1,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cefadroxil Targeting of SLC15A2/PEPT2 Protects From Colistin Nephrotoxicity 头孢羟氨苄靶向 SLC15A2/PEPT2 可防止可乐定的肾毒性。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-08 DOI: 10.1016/j.labinv.2024.102182
Raul Fernandez-Prado , Lara Valiño , Aranzazu Pintor-Chocano , Ana B. Sanz , Alberto Ortiz , Maria Dolores Sanchez-Niño
Acute kidney injury (AKI) and chronic kidney disease (CKD) are considered interconnected syndromes, as AKI episodes may accelerate CKD progression, and CKD increases the risk of AKI. Genome-wide association studies (GWAS) may identify novel actionable therapeutic targets. Human GWAS for AKI or CKD were combined with murine AKI transcriptomics data sets to identify 13 (ACACB, ACSM5, CNDP1, DPEP1, GATM, SLC6A12, AGXT2L1, SLC15A2, CTSS, ICAM1, ITGAX, ITGAM, and PPM1J) potentially actionable therapeutic targets to modulate kidney disease severity across species and the AKI-CKD spectrum. Among them, SLC15A2, encoding the cell membrane proton-coupled peptide transporter 2, was prioritized for data mining and functional intervention studies in vitro and in vivo because of its known function to transport nephrotoxic drugs such as colistin and the possibility for targeting with small molecules already in clinical use, such as cefadroxil. Data mining disclosed that SLC15A2 was upregulated in the tubulointerstitium of human CKD, including diabetic nephropathy, and the upregulation was localized to proximal tubular cells. Colistin elicited cytotoxicity and proinflammatory response in cultured human and murine proximal tubular cells that was decreased by concomitant exposure to cefadroxil. In proof-of-concept in vivo studies, cefadroxil protected from colistin nephrotoxicity in mice. The GWAS association of SLC15A2 with human kidney disease may be actionable and related to the modifiable transport of nephrotoxins causing repeated subclinical episodes of AKI and/or chronic nephrotoxicity.
急性肾损伤(AKI)和慢性肾脏病(CKD)被认为是相互关联的综合征,因为急性肾损伤发作可能会加速慢性肾脏病的进展,而慢性肾脏病会增加急性肾损伤的风险。全基因组关联研究(GWAS)可发现新的可操作治疗靶点。针对 AKI 或 CKD 的人类全基因组关联研究 (GWAS) 与小鼠 AKI 转录组学数据集相结合,确定了 13 个(ACACB、ACSM5、CNDP1、DPEP1、GATM、SLC6A12、AGXT2L1、SLC15A2、CTSS、ICAM1、ITGAX、ITGAM、PPM1J)潜在的可操作治疗靶点,以调节跨物种和跨 AKI-CKD 谱的肾病严重程度。其中,编码细胞膜质子偶联肽转运体 2 (PEPT2)的 SLC15A2 因其已知的转运肾毒性药物(如可乐定)的功能,以及与已用于临床的小分子药物(如头孢羟氨苄)靶向的可能性,被优先用于体外和体内的数据挖掘和功能干预研究。数据挖掘显示,SLC15A2 在人类慢性肾脏病(包括糖尿病肾病)的肾小管间质中上调,且上调定位于近端肾小管细胞。在培养的人类和小鼠近端肾小管细胞中,可乐定会引起细胞毒性和促炎反应,而同时暴露于头孢羟氨苄则会降低这种毒性和反应。在体内概念验证研究中,头孢羟氨苄能保护小鼠免受可乐定肾毒性的影响。SLC15A2 与人类肾脏疾病的 GWAS 关联可能是可操作的,并且与可改变的肾毒素转运有关,这种转运会导致反复的亚临床肾损伤和/或慢性肾毒性发作。
{"title":"Cefadroxil Targeting of SLC15A2/PEPT2 Protects From Colistin Nephrotoxicity","authors":"Raul Fernandez-Prado ,&nbsp;Lara Valiño ,&nbsp;Aranzazu Pintor-Chocano ,&nbsp;Ana B. Sanz ,&nbsp;Alberto Ortiz ,&nbsp;Maria Dolores Sanchez-Niño","doi":"10.1016/j.labinv.2024.102182","DOIUrl":"10.1016/j.labinv.2024.102182","url":null,"abstract":"<div><div>Acute kidney injury (AKI) and chronic kidney disease (CKD) are considered interconnected syndromes, as AKI episodes may accelerate CKD progression, and CKD increases the risk of AKI. Genome-wide association studies (GWAS) may identify novel actionable therapeutic targets. Human GWAS for AKI or CKD were combined with murine AKI transcriptomics data sets to identify 13 (<em>ACACB</em>, <em>ACSM5</em>, <em>CNDP1</em>, <em>DPEP1</em>, <em>GATM</em>, <em>SLC6A12</em>, <em>AGXT2L1</em>, <em>SLC15A2</em>, <em>CTSS</em>, <em>ICAM1</em>, <em>ITGAX</em>, <em>ITGAM</em>, and <em>PPM1J</em>) potentially actionable therapeutic targets to modulate kidney disease severity across species and the AKI-CKD spectrum. Among them, <em>SLC15A2</em>, encoding the cell membrane proton-coupled peptide transporter 2, was prioritized for data mining and functional intervention studies in vitro and in vivo because of its known function to transport nephrotoxic drugs such as colistin and the possibility for targeting with small molecules already in clinical use, such as cefadroxil. Data mining disclosed that <em>SLC15A2</em> was upregulated in the tubulointerstitium of human CKD, including diabetic nephropathy, and the upregulation was localized to proximal tubular cells. Colistin elicited cytotoxicity and proinflammatory response in cultured human and murine proximal tubular cells that was decreased by concomitant exposure to cefadroxil. In proof-of-concept in vivo studies, cefadroxil protected from colistin nephrotoxicity in mice. The GWAS association of <em>SLC15A2</em> with human kidney disease may be actionable and related to the modifiable transport of nephrotoxins causing repeated subclinical episodes of AKI and/or chronic nephrotoxicity.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 1","pages":"Article 102182"},"PeriodicalIF":5.1,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymphocyte Activation Gene 3 Expression, γδ T-Cell/Major Histocompatibility Complex Class I Interactions, and Prognosis in Merkel Cell Carcinoma 梅克尔细胞癌中的 LAG-3 表达、γδ-T 细胞/MHC-I 相互作用和预后
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-05 DOI: 10.1016/j.labinv.2024.102178
Jonathan Lai , Vrinda Madan , Aasheen Qadri , Ludmila Danilova , Long Yuan , Victoria Jacobs , Aleksandra Ogurtsova , Logan L. Engle , Joel C. Sunshine
Merkel cell carcinoma (MCC) is an aggressive cutaneous malignancy with a poor prognosis. One of the major mechanisms of immune evasion in MCC involves downregulation of major histocompatibility complex class I (MHC-I). Anti-PD-1/programmed death ligand 1 checkpoint inhibitors have revolutionized treatment for MCC, producing objective responses in approximately 50% of patients, and are now the standard of care; however, a substantial proportion of patients either fail to respond or develop resistance to checkpoint inhibitors. Given these recent successes, identification of other targetable immune checkpoints in the MCC tumor microenvironment is of great interest. Additionally, γδ T cells may play critical roles in response to MHC-I–deficient cancers; therefore, evaluating γδ T cells as a prognostic biomarker is warranted. We characterized the expression of programmed death ligand 1, PD-1, CD3, CD8, lymphocyte activation gene 3 (LAG-3), MHC-I, and γδ T cells by immunohistochemistry in a preimmunotherapy retrospective cohort of 54 cases of MCC and quantified expression levels and marker density using HALO software. The increased density of LAG-3 and γδ T cells correlated with other markers of an inflamed tumor microenvironment, with significant positive associations across all 6 markers (P < .002). Reflective of their putative role in the response to MHC-I–suppressed cancers, cases with low human leukocyte antigen I density showed a trend toward a higher ratio of γδ T cells:CD3+ T cells (Spearman r = −0.1582; P = .21). Importantly, high CD3 density (hazard ratio [HR], 0.23; P = .002), LAG-3 density (HR, 0.47; P = .037), γδ T-cell density (HR, 0.26; P = .02), and CD8 density (HR, 0.27; P = .03) showed associations with improved progression-free survival. Conditional tree analysis demonstrated that high CD8 and TCRδ expression were nonsignificant predictors of improved progression-free survival and overall survival. Overall, LAG-3 is expressed in MCC infiltrates and is prognostic in preimmunotherapy MCC, suggesting a potential role for LAG-3 inhibition in MCC. Additionally, CD8 and γδ T cells may play a critical role in the response to MCC, and γδ T-cell density may represent a novel biomarker in MCC.
梅克尔细胞癌(MCC)是一种侵袭性皮肤恶性肿瘤,预后较差。MCC 免疫逃避的主要机制之一涉及 MHC-I 的下调。抗PD-1/PD-L1检查点抑制剂(CKIs)彻底改变了MCC的治疗,使50%的患者产生了客观反应,现已成为标准治疗方法;然而,相当一部分患者对CKIs没有反应或产生了耐药性。鉴于最近取得的这些成功,在 MCC 肿瘤微环境(TME)中识别其他可靶向的免疫检查点引起了极大的兴趣。此外,γ-δ(γδ)T 细胞可能在对 MHC-I 缺乏的癌症的反应中发挥关键作用;因此,有必要评估作为预后生物标志物的γδ-T 细胞。我们在54例MCC免疫治疗前回顾性队列中通过IHC鉴定了PD-L1、PD-1、CD3、CD8、LAG-3、MHC-I和γδ-T细胞的表达,并通过HALO量化了表达水平和标记物密度。LAG-3和γδ-T细胞密度的增加与发炎的TME的其他标记物相关,所有六种标记物都有显著的正相关性(p
{"title":"Lymphocyte Activation Gene 3 Expression, γδ T-Cell/Major Histocompatibility Complex Class I Interactions, and Prognosis in Merkel Cell Carcinoma","authors":"Jonathan Lai ,&nbsp;Vrinda Madan ,&nbsp;Aasheen Qadri ,&nbsp;Ludmila Danilova ,&nbsp;Long Yuan ,&nbsp;Victoria Jacobs ,&nbsp;Aleksandra Ogurtsova ,&nbsp;Logan L. Engle ,&nbsp;Joel C. Sunshine","doi":"10.1016/j.labinv.2024.102178","DOIUrl":"10.1016/j.labinv.2024.102178","url":null,"abstract":"<div><div>Merkel cell carcinoma (MCC) is an aggressive cutaneous malignancy with a poor prognosis. One of the major mechanisms of immune evasion in MCC involves downregulation of major histocompatibility complex class I (MHC-I). Anti-PD-1/programmed death ligand 1 checkpoint inhibitors have revolutionized treatment for MCC, producing objective responses in approximately 50% of patients, and are now the standard of care; however, a substantial proportion of patients either fail to respond or develop resistance to checkpoint inhibitors. Given these recent successes, identification of other targetable immune checkpoints in the MCC tumor microenvironment is of great interest. Additionally, γδ T cells may play critical roles in response to MHC-I–deficient cancers; therefore, evaluating γδ T cells as a prognostic biomarker is warranted. We characterized the expression of programmed death ligand 1, PD-1, CD3, CD8, lymphocyte activation gene 3 (LAG-3), MHC-I, and γδ T cells by immunohistochemistry in a preimmunotherapy retrospective cohort of 54 cases of MCC and quantified expression levels and marker density using HALO software. The increased density of LAG-3 and γδ T cells correlated with other markers of an inflamed tumor microenvironment, with significant positive associations across all 6 markers (<em>P</em> &lt; .002). Reflective of their putative role in the response to MHC-I–suppressed cancers, cases with low human leukocyte antigen I density showed a trend toward a higher ratio of γδ T cells:CD3+ T cells (Spearman <em>r</em> = −0.1582; <em>P</em> = .21). Importantly, high CD3 density (hazard ratio [HR], 0.23; <em>P</em> = .002), LAG-3 density (HR, 0.47; <em>P</em> = .037), γδ T-cell density (HR, 0.26; <em>P</em> = .02), and CD8 density (HR, 0.27; <em>P</em> = .03) showed associations with improved progression-free survival. Conditional tree analysis demonstrated that high CD8 and TCRδ expression were nonsignificant predictors of improved progression-free survival and overall survival. Overall, LAG-3 is expressed in MCC infiltrates and is prognostic in preimmunotherapy MCC, suggesting a potential role for LAG-3 inhibition in MCC. Additionally, CD8 and γδ T cells may play a critical role in the response to MCC, and γδ T-cell density may represent a novel biomarker in MCC.</div></div>","PeriodicalId":17930,"journal":{"name":"Laboratory Investigation","volume":"105 1","pages":"Article 102178"},"PeriodicalIF":5.1,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laboratory Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1